Literature DB >> 16186271

Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study.

Nicola Scopinaro1, Giuseppe Maria Marinari, Giovanni Bruno Camerini, Francesco Saverio Papadia, Gian Franco Adami.   

Abstract

OBJECTIVE: Gastric bypass and biliopancreatic diversion (BPD) are known to have a beneficial effect on glucose metabolism superior to that of the other bariatric operations. Thanks to its excellent weight loss results and to its specific actions, BPD has proven able to guarantee permanent normalization of serum glucose, triglyceride, and cholesterol levels in the vast majority, if not the totality, of operated patients. However, clinical studies on the duration of these effects in large patient populations are still lacking. RESEARCH DESIGN AND METHODS: The files of 312 BPD obese patients with type 2 diabetes operated on from June 1984 to January 1993 were examined. Pre- and postoperative serum glucose, triglyceride, and cholesterol levels, along with arterial pressure measurements, were considered.
RESULTS: After BPD, fasting serum glucose concentration fell within normal values in all but two of the operated subjects and remained in the physiological range in all but six up until 10 years. Serum triglyceride and total cholesterol steadily normalized in all subjects with abnormally high preoperative values, and arterial hypertension disappeared in the vast majority of the preoperatively hypertensive patients.
CONCLUSIONS: BPD proved able to reverse all the major components of the metabolic syndrome in nearly all the operated subjects, with results being strictly maintained over a 10-year follow-up period. This outcome, which far exceeds those following similar weight loss at short or long term obtained by any other means, confirms the existence of specific actions of BPD on the major components of metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186271     DOI: 10.2337/diacare.28.10.2406

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  72 in total

1.  Mouse Models of Bariatric Surgery.

Authors:  Deng Ping Yin; Kelli L Boyd; Phillip E Williams; Naji N Abumrad; David H Wasserman
Journal:  Curr Protoc Mouse Biol       Date:  2012-12-01

Review 2.  Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors:  Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

Review 3.  [Metabolic surgery].

Authors:  C Jurowich; C T Germer; F Seyfried; A Thalheimer
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

4.  Laparoscopic versus open biliopancreatic diversion: a prospective comparative study.

Authors:  Valerio Ceriani; Tiziana Lodi; Andrea Porta; Paolo Gaffuri; Edoardo Faleschini; Oscar Roncaglia; Chiara Osio; Massimiliano Coladonato; Ahmed Elnabil-Mortada
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

5.  Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity.

Authors:  Nicola Crea; Giacomo Pata; Ernesto Di Betta; Francesco Greco; Claudio Casella; Antonio Vilardi; Francesco Mittempergher
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

Review 6.  Is type 2 diabetes a surgical disease?

Authors:  Mehran Anvari
Journal:  Can J Surg       Date:  2007-08       Impact factor: 2.089

7.  Biliopancreatic diversion in a renal transplant patient.

Authors:  Maite López Deogracias; Agustin Domínguez-Diez; Rosa Palomar-Fontanet; Monica González-Noriega; E Rodrigo; G Fernández-Fresnedo; J A Zubimendi; Francisco Olmedo; Manuel Gómez-Fleitas; M Arias; Carlos Fernández-Escalante
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

Review 8.  Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss.

Authors:  Gian Franco Adami; Nicola Scopinaro; Renzo Cordera
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

9.  Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity.

Authors:  Theodore K Alexandrides; George Skroubis; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

10.  Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2.

Authors:  Nicola Scopinaro; Francesco Papadia; Giuseppe Marinari; Giovanni Camerini; Gianfranco Adami
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.